2020 Speaker List:

 

Recombinant Protein Therapeutics

[KEYNOTE] Aris N. Economides, PhD, Vice President, Research, Regeneron Pharmaceuticals, Inc.

Katharina Billian-Frey, PhD, Senior Scientist, Protein Engineering, Drug Discovery, Apogenix AG

Ruben J. Boado, PhD, Co-Founder, ArmaGen, Inc.

Alan Epstein, MD, PhD, Professor, Pathology, Keck School of Medicine, University of Southern California (USC)

Jennifer Cochran, PhD, Professor, Bioengineering and Chemical Engineering, and Shriram Chair, Bioengineering, Stanford University

Joachim Feldswich, PhD, Director, Preclinical Development, Affibody AB

Elissa Leonard, PhD, Postdoctoral Research Fellow, Biomedical Engineering, Johns Hopkins University

Bharat Madan, PhD, Postdoctoral Researcher, Pharmaceutical Chemistry, University of Kansas

Shannon K. Oda, PhD, Research Associate, Philip D. Greenberg Laboratory, Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center

Mark Rixon, PhD, Senior Director, Protein Therapeutics, Alpine Immune Sciences

Lu Shan, PhD, Scientist, Antibody Discovery and Protein Engineering, AstraZeneca plc

Stefan Schmidt, PhD, MBA, COO/Head, Operations, BioAtrium AG

Rachita Sumbria, PhD, Associate Professor, Biopharmaceutical Sciences, Keck Graduate Institute

Yariv Wine, PhD, Assistant Professor, Molecular Cell Biology and Biotechnology, Tel Aviv University

 

Lead and Candidate Selection for Therapeutic Proteins

[KEYNOTE] Peter M. Tessier, PhD, Professor, Pharmaceutical Sciences, Chemical Engineering and Biomedical Engineering, University of Michigan

Karl Griswold, PhD, Associate Professor, Engineering, Dartmouth College

Kate Hastie, PhD, Instructor, La Jolla Institute for Immunology

Vibha Jawa, PhD, Director, Risk Assessment and Clinical Immunogenicity, Merck

Jonathan Kingsbury, PhD, Senior Director, Developability & Preformulation Science, Sanofi

Chang Liu, PhD, Associate Scientist, BioAnalytical Sciences, Genentech

Rajiv Panwar, PhD, Principal Scientist, Magenta Therapeutics

Samantha Phan, Consultant Biologist, Protein BioSciences, Eli Lilly and Company

Ramkrishna (Ramu) Sadhukhan, PhD, Principal Research Scientist, Global Protein Sciences, AbbVie Bioresearch Center

Daniel-Adriano Silva, PhD, Vice President, Head of Research, Neoleukin Therapeutics, Inc.

Max Vásquez, PhD, Head, Computational Biology, Adimab LLC

Sathya Venkataramani, PhD, Associate Director, Biophysics, Janssen Biotherapeutics

 

Deep Sequencing and Single Cell Analysis for Antibody Discovery

[KEYNOTE] Bryan Briney, PhD, Assistant Professor, Immunology and Microbiology, The Scripps Research Institute

Jarrett Adams, PhD, Associate Director, Toronto Recombinant Antibody Center, Canada

Andrew R.M. Bradbury, MB BS, PhD, CSO, Specifica, Inc.

Sean Carroll, PhD, Associate Director, Molecular Biology, Atreca

Stefan Ewert, PhD, Senior Investigator, Novartis Pharma AG, Switzerland

Elke Glasmacher, PhD, Head, Immunobiology, Roche, Germany

Jimmy Gollihar, PhD, Research Scientist, Army Futures Command, Army Research Laboratory

Ryan Kelly, PhD, Research Scientist, xCella Biosciences

Yana Safonova, PhD, Postdoctoral Fellow, Computer Science and Engineering Department, University of California San Diego

Aude Segaliny, PhD, Group Leader, Assay Biology & Scientific Liaison, Amberstone Biosciences

Vu Truong, PhD, CSO & CEO, R&D, Aridis Pharmaceuticals, Inc.

Navin Varadarajan, PhD, Associate Professor, Chemical and Biomolecular Engineering, University of Houston

Alon Wellner, PhD, Postdoctoral Research, Biomedical Engineering, University of California, Irvine

Alexander Yermanos, Researcher, Biosystems Science and Engineering, ETH Zurich, Switzerland

 

Engineering Next-Generation Cancer Immunotherapies

[KEYNOTE] Shahram Salek-Ardakani, PhD, Senior Director, Cancer Immunology Discovery, Pfizer

Hamsell Alvarez, PhD, Principal Research Scientist, Immuno-Oncology Discovery, AbbVie

Javier Chaparro-Riggers, PhD, Senior Director, Protein Engineering, Pfizer

Kathryn Henckels, PhD, Senior Scientist, Process Development, Amgen

Michael Hedvat, PhD, Group Leader, Cell Biology, Xencor

Mitchell Ho, PhD, Senior Investigator, National Cancer Institute, NIH

Noor Jailkhani, PhD, Postdoctoral Research Scientist, Koch Institute for Integrative Cancer Research, MIT

Hitoshi Katada, PhD, Research Scientist, Biologics Discovery, Chugai Pharmaceutical Co., Ltd., Japan

Sean H. Lim, MBChB, PhD, Associate Professor, Haematological Oncology, Center for Cancer Immunology, University of Southampton, United Kingdom

Lance L. Munn, PhD, Associate Professor, Department of Radiation Oncology, Massachusetts General Hospital

Govinda Sharma, PhD, Postdoctoral Fellow, Genome Sciences Center, BC Cancer Research Center, Canada

Traian Sulea, PhD, Principal Research Officer, Human Health Therapeutics, National Research Council Canada

 

Antibody-Drug Conjugates

[KEYNOTE] Rakesh Dixit, PhD, DABT, President & CEO, Bionavigen, LLC

George Octavian Badescu, PhD, Vice President, Scientific Affairs, Heidelberg Pharma AG

Maria J. Costa, PhD, Associate Director, Research, Immune-Onc Therapeutics, Inc.

Tony D’Alessio, PhD, Senior Research Investigator, Oncology Biotherapeutics, Novartis Institutes for Biomedical Research

Susanna Elledge, MSc, Scientist, Chemistry and Chemical Biology, University of California, San Francisco (UCSF)

Mark Glassy, PhD, Chairman, Nascent Biotech, Inc.

Amelie Eriksson Karlström, PhD, Professor, Protein Sciences, Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology

Qing Li, PhD, Scientist, Antibody Discovery & Protein Engineering, AstraZeneca

Adrian Hobson, PhD, Research Fellow, Global Biologics – Antibody Drug Conjugates, AbbVie Bioresearch Center, AbbVie

Bradley Pearse, PhD, Director, Biotherapeutics, Magenta Therapeutics

Siew Schleyer, PhD, Director, Oncology Research, CytomX Therapeutics, Inc.

Edit Tarcsa, PhD, Director and Research Fellow, Drug Metabolism & Pharmacokinetics, Abbvie Bioresearch Center, AbbVie

Jonathan van Dyck, Scientist, Analytical Sciences, Seattle Genetics

 

Bispecific Antibody Therapeutics

[KEYNOTE] Partha S. Chowdhury, Senior Director, Biologics Research, Sanofi Genzyme

Ulrich Brinkmann, PhD, Expert Scientist and Scientific Director, Roche Pharma Research & Early Development, Roche Innovation Center Munich

Stephen Demarest, PhD, Senior Research Fellow, Lilly Biotechnology Center, Eli Lilly and Company

David J. DiLillo, PhD, Senior Staff Scientist, Immuno-Oncology, Regeneron Pharmaceuticals

Christina Furebring, PhD, Senior Vice President, Preclinical Development, Alligator Bioscience

Steffen Goletz, PhD, Professor and Deputy Head, Biotechnology and Biomedicine, and Vice Director, Institute of Bioengineering, Technical University of Denmark

James Legg, PhD, Senior Vice President, Research, Crescendo Biologics, Ltd.

Shaun Lippow, PhD, Director, Protein Engineering, Atreca, Inc.

Sebastian Meyer, PhD, Chief Operating Officer, Numab Therapeutics AG

Wendy Ritacco, MSc, Senior Scientist III, Global Biologics, AbbVie

Justin Scheer, PhD, Director, Antibody Engineering, Boehringer Ingelheim

Jamie B. Spangler, PhD, Assistant Professor, Biomedical Engineering and Chemical & Biomolecular Engineering, Whiting School of Engineering, Johns Hopkins University

David E. Szymkowski, PhD, Vice President, Cell Biology, Xencor, Inc.

Nathan Trinklein, PhD, Chief Technology Officer, TeneoBio, Inc.

 

Vector Design and Development for Gene and Cell Therapies

[KEYNOTE] Guangping Gao, PhD, Co-Director, Li Weibo Institute for Rare Diseases Research; Director, Horae Gene Therapy Center and Viral Vector Core; Professor, Microbiology and Physiological Systems, University of Massachusetts Medical School

Annicka Evans, PhD, Scientist I, Analytical Development, Gene Therapy, Biogen

Justin Eyquem, PhD, Principal Investigator, Department of Microbiology and Immunology, University of California San Francisco

Tyler Gibson, PhD, Scientist II, Decibel Therapeutics

Karmella Haynes, PhD, Assistant Professor, Wallace H. Coulter Department of Biomedical Engineering, Emory University

Douglas Jolly, PhD, Executive Vice President, Research & Pharmaceutical Development, Tocagen, Inc.

Jing Liao, PhD, Associate Director, Discovery Biology, LogicBio Therapeutics

Andrew Mercer, PhD, Principal Scientist, Gene Transfer Technologies, REGENXBIO

Francis C. Szoka, PhD, Professor of Bioengineering, Therapeutic Sciences and Pharmaceutical Chemistry, University of California, San Francisco

Christopher Tipper, PhD, MS, Director of Discovery Research, Ophthalmology, Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary

Jiwu Wang, PhD, President and CEO, Allele Biotech

Ziying Yan, PhD, Research Associate Professor, Department of Anatomy and Cell Biology, The University of Iowa

Peter Yingxiao Wang, PhD, Professor, Bioengineering, Institute of Engineering in Medicine, University of California, San Diego

 

Gene Therapy Analytics and Manufacturing

[KEYNOTE] Muthiah (Mano) Manoharan, PhD, Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals, Inc.

David Cetlin, Founder & CEO, MockV Solutions LLC

Mark Galbraith, PhD, Head, Quality Control and Analytical Sciences, Spark Therapeutics

Mo Heidaran, PhD, Vice President, Technical, PAREXEL Consulting, PAREXEL International

Arun Alphonse Ignatius, PhD, Principal Scientist, Pharmaceutical Research and Development, Biotherapeutics, Pfizer, Inc.

Jichao (Jay) Kang, PhD, RAC, Director, Analytical Development, Amicus Therapeutics

Alfred Luitjens, Director Cell Technology, Operations, Batavia Biosciences

Lake N. Paul, PhD, President, BioAnalysis, LLC

Jim Richardson, PhD, Senior Science and Standards Liaison, Global Biologics, United States Pharmacopeia

Klaus Richter, PhD, Group Leader, Analytical Ultracentrifugation (AUC) Group, Coriolis Pharma Research

Tanvir Tabish, MSc, Head of Formulation Development, Formulation, Fill and Finish, Takeda

Tristan Thwaites, PhD, Lead Technical Scientist, Industrialization, Cell and Gene Therapy Catapult

Qin Zou, PhD, Associate Research Fellow and Group Leader, Analytical Research and Development, Pfizer, Inc.

 

Cell Therapy Analytics and Manufacturing

[KEYNOTE]-Mo Heidaran, PhD, Vice President, Technical, PAREXEL Consulting, PAREXEL International

Debaditya Bhattacharya, PhD, Group Leader, Analytical Cell & Gene Therapy, Process & Analytical Development, bluebird bio

Vijay Chiruvolu, PhD, Senior Vice President of Global Process Development - Cell Therapy, Kite Pharma, a Gilead Sciences Company

Dominic Clarke, PhD, ISCT Process & Product Committee Co-Chair and Global Head, Cell Therapy, HemaCare

Ta-Chun Hang, PhD, Senior Scientist, Process Development, bluebird bio

Tony Bou Kheir, PhD, Senior Analytical Development Scientist, Cell and Gene Therapy Catapult

Kelly Kemp, PhD, Director, Process Development, ViaCyte

Sandro Matosevic, PhD, Assistant Professor, Department of Industrial and Physical Pharmacy, Purdue University

Shabnum Patel, PhD, Process Development & Manufacturing Scientist, Center for Cancer Cell Therapy, Stanford University

Jim Richardson, PhD, Senior Science and Standards Liaison, Global Biologics, United States Pharmacopeia

Ilya Shestopalov, PhD, Associate Director, Cell Analytics, bluebird bio

Kuldip Sra, PhD, Senior Director, Crispr Therapeutics

Tristan Thwaites, PhD, Lead Technical Scientist, Industrialization, Cell and Gene Therapy Catapult

 

Optimizing Biologics Formulation Development

[KEYNOTE] Murali Bilikallahalli, PhD, Vice President and Head of Technical Operations, Acceleron Pharma

Aniket Badkar, PhD, Director, Biologics Product Development, Allergan

Ralf Carrillo, PhD, Associate Principal Scientist, Pharmaceutical Science, Merck

Julie Champion, PhD, Associate Professor, Chemical and Biomolecular Engineering, Georgia Tech

Jessica Ebo, Researcher, Astbury Center for Structural Molecular Biology, University of Leeds, United Kingdom

Flaviu Gruia, PhD, Principal Scientist, Drug Product Analytical Development, Moderna Therapeutics

Kapil Gupta, PhD, Director, Protein Pharmaceutical Development, Biogen

Saeed Izadi, PhD, Scientist, Genentech

Xiaofeng Lu, PhD, Principal Research Scientist, Pharmaceutical Development, AbbVie, Inc.

Krishna M.G. Mallela, PhD, Associate Professor, Pharmaceutical Sciences, University of Colorado

Page McAndrew, PhD, Director, Scientific Communications, West Pharmaceutical Services

Shalini Minocha, PhD, Staff Scientist, Formulation Development, Regeneron

Samantha Pace, PhD, Research Investigator, Bristol-Myers Squibb

Jainik Panchal, PhD, Associate Principal Scientist, Sterile Formulation Sciences, Merck

 

Lyophilization and Emerging Drying Technologies

[KEYNOTE] Gerhard Winter, PhD, Professor, Chair, Pharmaceutical Technology and Biopharmaceutics, LMU Munchen

Arun Alphonse Ignatius, PhD, Principal Scientist, Pharmaceutical Research and Development, Biotherapeutics, Pfizer, Inc.

Bakul Bhatnagar, PhD, Senior Principal Scientist, Pharmaceutical R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer, Inc.

Pauline Che, MSc, Engineer II, Pharmaceutical Development, Genentech

Benson Gikanga, Senior Engineer, Pharmaceutical Processing and Technology Development, Genentech

[FEATURED PRESENTER] Xiuling Lu, PhD, Associate Professor, Pharmaceutical Sciences, University of Connecticut

Andrew Massetti, Senior Associate Scientist, Protein Pharmaceutical Development, Biogen

Rajiv Nayar, PhD, President, HTD Biosystems, Inc.

Evgenyi Shalaev, PhD, Executive Director, Pharmaceutical Development, Allergan plc

Justin Stanbro, PhD, Associate Principal Scientist, Novel Adjuvants, Formulation & Delivery Technologies, Merck & Co.

Tanvir Tabish, MSc, Head of Formulation Development, Formulation, Fill and Finish, Takeda

Xiaoda Yuan, PhD, Scientist, Pharmaceutical Development, Allergan, Inc.

 

Protein Aggregation and Emerging Analytical Tools

[KEYNOTE] Peter Schurtenberger, PhD, Professor, Department of Chemistry, Lund University

Paolo Arosio, PhD, Professor, Biochemical Engineering, Department of Chemistry and Applied Biosciences, ETH Zurich

Christoph Brandenbusch, PhD, Group Leader, Biochemical and Chemical Engineering, TU Dortmund

John J. Correia, PhD, Professor, Department of Biochemistry, University of Mississippi Medical Center

Reza Esfandiary, Associate Director, Early Stage Formulation Sciences, BioPharmaceutical Development, AstraZeneca

Jan Jezek, PhD, CSO, Arecor Ltd.

Andrzej Kloczkowski, PhD, Professor, Pediatrics, Nationwide Children’s Hospital and The Ohio State University

Thomas Laue, PhD, Professor Emeritus, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire

Christian Lange, PhD, R&D Biologics Research, Assays and Analytics, Protein Therapeutics, Sanofi-Aventis Deutschland GmbH

Gerhard Winter, PhD, Professor, Chair, Pharmaceutical Technology and Biopharmaceutics, LMU Munchen

Marcel Tigges, PhD, Associate Director, The Janssen Pharmaceutical Companies of Johnson & Johnson

Josh Tokuda, PhD, Postdoctoral Fellow, Biological Relevance and Characterization, Amgen, Inc.

Vishal Toprani, PhD, Development Scientist-I, Pharmaceutical Development, Alexion Pharmaceuticals

 

Characterization of Biotherapeutics

[KEYNOTE] Elizabeth M. Topp, PhD, Dane O. Kildsig Chair and Department Head, Department of Industrial and Physical Pharmacy, Purdue University

[Featured Presenter] Anup Arumughan, PhD, Principal Scientist, Antibody Analytics, Roche

Gaurav Chauhan, MS, Associate Principal Scientist, Biologics Process Research and Development, Merck & Co., Inc.

Suzanne D’Addio, PhD, Principal Scientist - Discovery Pharmaceutical Sciences, Merck & Co., Inc.

Mark Chiu, PhD, Associate Director, BioTherapeutics Analytical Development, Janssen Research & Development LLC

David Hayes, PhD, Biophysics Consultant, International Solidarity of Scientists

Nate Joh, PhD, Senior Scientist, Biological Relevance and Characterization, Amgen, Inc.

Robert Mayer, PhD, Senior Fellow, Novartis - Global Drug Development, Technical Research & Development, Sandoz GmbH

Mitra Mosharraf, PhD, HTD Biosystems, Inc.

Sheila Mugabe, MSc, Scientist, MacroGenics, Inc.

Sanket Patke, PhD, Senior Scientist, Drug Product Formulation and Process Development, Sanofi

Peter Schurtenberger, PhD, Professor, Department of Chemistry, Lund University

Alayna George Thompson, PhD, Senior Scientist I, Drug Discovery Science & Technology, AbbVie

Riccardo Torosantucci, PhD, Section Head - Formulation & Process Development Frankfurt, Biologics Drug Product Development, Sanofi

 

Detection and Characterization of Particulates and Impurities

[KEYNOTE] Paolo Arosio, PhD, Professor, Biochemical Engineering, Department of Chemistry and Applied Biosciences, ETH Zurich

Samiul Amin, PhD, Associate Professor, Chemical Engineering, Manhattan College

Richard Cavicchi, PhD, Research Physicist, Biomolecular Measurement Division, Material Measurement Laboratory, National Institute of Standards and Technology

David Cetlin, Founder & CEO, MockV Solutions LLC

Rachel Chen, Scientist II, Analytical Development, Biogen

Danny K. Chou, PharmD, PhD, President, Biopharmaceutical Characterization and Formulation Development, Compassion BioSolution, LLC

Joel F. Cohen-Solal, PhD, Senior Scientist, Global Protein Sciences, AbbVie Bioresearch Center, Inc.

Rui Fang, PhD, Senior Scientist, Sterile Formulation Sciences, Merck & Co., Inc.

Mark Galbraith, PhD, Head, Quality Control and Analytical Sciences, Spark Therapeutics

Tristan Thwaites, PhD, Lead Technical Scientist, Industrialization, Cell and Gene Therapy Catapult

Sandy Wang, MSc, Engineer II, Pharmaceutical Development, Genentech

Boxu Yan, PhD, Senior Director, Analytical Development and Quality Control, Acceleron Pharma

Qin Zou, PhD, Associate Research Fellow and Group Leader, Analytical Research and Development, Pfizer, Inc.

 

Bioprocess Data Management and Analysis

[KEYNOTE] Cenk Undey, PhD, Executive Director, Process Development, Amgen

Norbert Furtmann, PhD, Head of Data Lab, High Throughput Biologics, Sanofi-Aventis Deutschland GmbH

Jin Sung Hong, PhD, ORISE Research Fellow, Center for Drug Evaluation and Research, FDA

Bryan E. Jones, PhD, Research Fellow, BioTechnology Discovery Research, Eli Lilly and Company

Meiyappan Lakshmanan, PhD, Research Scientist & Group Leader, Systems Biology, Bioprocessing Technology Institute, A*STAR

Nathan E. Lewis, PhD, Associate Professor, Department of Pediatrics, University of California, San Diego

Ruojia Li, PhD, Principal Scientist, Statistics Team Lead, Biologics Development, Bristol-Myers Squibb

Yuan Lin, Biologics Solution Lead, Pfizer, Inc.

Jonathan Mott, MS, Scientist, Upstream Process Sciences, Nektar Therapeutics

Anne Richelle, PhD, Senior Specialist - Metabolic Modeling, Global Vaccines, Technical R&D, GlaxoSmithKline Vaccines

Khandaker Siddiquee, PhD, Principal Scientist, Abbott Diagnostic Division, Abbott Laboratories

Thomas Zahel, PhD, Head of Innovation, Exputec GmbH

Jesus Zaragoza, Solutions Architect, TetraScience

 

Protein Purification and Recovery

[KEYNOTE] Alois Jungbauer, PhD, Professor and Head, Institute of Bioprocess Science and Engineering, Biotechnology, University of Natural Resources and Life Sciences (BOKU)

Richard Altman, MS, Staff Scientist, Life Science Solutions, Thermo Fisher Scientific

Mark Howarth, PhD, Professor, Biochemistry, University of Oxford

Dennis Karthaus, MSc, Group Leader Cell Culture Sciences, IBA Lifesciences

John K. Kawooya, PhD, Director, Biologics Optimization, Discovery Research, Amgen, Inc.

Wan-Ching Lai, PhD, Principal Scientist, Diagnostics, Abbott Laboratories

Abraham M. Lenhoff, PhD, Allan P. Colburn Professor, Chemical and Biomolecular Engineering, University of Delaware

Simon Messing, PhD, Scientist II, Protein Expression Laboratory, Leidos Biomedical/Frederick National Laboratory for Cancer Research

Timothy M. Pabst, PhD, Principal Scientist, Protein Purification & Downstream Process Development, AstraZeneca

Rumana Rashid, PhD, Lead Scientist, Protein Sciences, Xencor, Inc.

Corey Smith, PhD, Senior Scientist, Abbvie Bioresearch Center

Lu Wang, PhD, Associate Director, CMC Process Development, Teva Pharmaceuticals USA, Inc.

Gregory Weiss, PhD, Professor, Chemistry, Pharmaceutical Sciences, Molecular Biology & Biochemistry, University of California, Irvine

David Wood, PhD, Professor, Chemical and Biomolecular Engineering, Microbiology, Chemistry & Biochemistry, Ohio State University

Yan-ping Yang, PhD, Associate Vice President and Head, Bioprocess R&D, North America, Sanofi Pasteur

Alexei Yeliseev, PhD, Staff Scientist and Leader, Protein Expression Group, NIH

 

Higher-Throughput Protein Production and Characterization

[KEYNOTE] Renaud Vincentelli, PhD, Head, High-Throughput Protein Production, Structural Biology Core, Architecture et Fonction des Macromolécules Biologiques (AFMB), UMR, CNRS – Aix-Marseille University

Christopher Bahl, PhD, Head, Protein Design, Protein Design Laboratory, Institute for Protein Innovation

Nicola Burgess-Brown, PhD, Principal Investigator, Nuffield Department of Medicine, SGC, University of Oxford

Jörg Birkenfeld, PhD, Section Head, High-Throughput Biologics, R&D Biologics Research/Protein Therapeutics, Sanofi-Aventis Deutschland GmbH

Yongku Cho, PhD, Assistant Professor, Chemical and Biomolecular Engineering, University of Connecticut

Sabine Eichling, PhD, Head, Advanced Formulation Development, NBE Formulation Sciences, AbbVie Deutschland GmbH & Co KG

Markus Haberger, Group Leader, Development Characterization Analytics, Roche Diagnostics GmbH

Liviu Movileanu, PhD, Professor, Physics, Biomedical and Chemical Engineering, Syracuse University

Vel Murugan, PhD, MBA, Research Scientist, Virginia G. Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University

Jürgen Nett, PhD, Director, High-Throughput Expression, Adimab, LLC

Sarah Rue, PhD, Associate Director, Advanced Automation Technologies, Genomics Institute of the Novartis Research Foundation (GNF)

Peng George Wang, PhD, Professor, Pharmacology and Chemical Biology, Baylor College of Medicine

Ernst Weber, PhD, Laboratory Head, Biologics Lead Optimization and Project Leader, Ophthalmology, Bayer Healthcare AG

Renaud Vincentelli, PhD, Head, High-Throughput Protein Production, Structural Biology Core, Architecture et Fonction des Macromolécules Biologiques (AFMB), UMR, CNRS – Aix-Marseille University

Daniel Yoo, Scientist, Therapeutic Discovery, Biologics Optimization, Amgen, Inc.

 

Engineering Genes, Vectors, Constructs, and Clones

[KEYNOTE] Josh LaBaer, MD, PhD, Executive Director, Biodesign Institute, Arizona State University

Jeffrey Barrick, PhD, Associate Professor, Molecular Biosciences, The University of Texas at Austin

David Burgenson, PhD Candidate, Center for Advanced Sensor Technology (CAST), University of Maryland Baltimore County

Karmella Haynes, PhD, Assistant Professor, Wallace H. Coulter Department of Biomedical Engineering, Emory University

Chava Kimchi-Sarfaty, PhD, Deputy Associate Director for Research, Office of Tissues and Advanced Therapies, CBER, FDA

Antje Krüger, PhD, Postdoctoral Fellow, Michael Jewett Laboratory, Department of Chemical and Biological Engineering, Northwestern University

Meiyappan Lakshmanan, PhD, Research Scientist & Group Leader, Systems Biology, Bioprocessing Technology Institute, A*STAR

Nathan E. Lewis, PhD, Associate Professor, Department of Pediatrics, University of California, San Diego

Jing Liao, PhD, Associate Director, Discovery Biology, LogicBio Therapeutics

Tomoshi Kameda, PhD, Senior Research Scientist, National Institute of Advanced Industrial Science and Technology

Javin P. Oza, PhD, Assistant Professor, Chemistry & Biochemistry, California Polytechnic State University, SLO

Harun Rashid, PhD, Senior Principal Scientist, Molecular Technology, Ambrx, Inc.

Samuel H. Sternberg, PhD, Assistant Professor, Department of Biochemistry and Molecular Biophysics, Columbia University

Francis C. Szoka, PhD, Professor of Bioengineering, Therapeutic Sciences and Pharmaceutical Chemistry, University of California, San Francisco

Recombinant Protein Expression and Production

[KEYNOTE] Phillip Berman, PhD, Distinguished Research Professor, Biomolecular Engineering, University of California, Santa Cruz

Johannes Buyel, Dr. rer. nat., Dr-Ing, Head, Bioprocess Engineering, Fraunhofer Institute for Molecular Biology and Applied Ecology IME

Charles A. Glass, PhD, President and CSO, TEGA Therapeutics, Inc.

Olivier Henry, PhD, Associate Professor, Chemical Engineering, Polytechnique Montréal

Nobuko Katagiri, PhD, Research Biologist, Division of Plasma Protein Therapeutics, Office of Tissues and

Takeshi Omasa, PhD, Professor, Department of Material and Life Science, Graduate School of Engineering, Osaka University

Shirley Peters, PhD, Principal Scientist, UCB

Tyson Shepherd, Research Associate, Mark Bathe Laboratory, Department of Biological Engineering, Massachusetts Institute of Technology

Danming Tang, PhD, Technical Development Scientist, Cell Culture, Genentech

Brian Vandahl, PhD, Corporate Vice President, Recombinant Technologies, Global Research Technologies, Novo Nordisk A/S

Bjørn Voldborg, MSc, Director, CHO Cell Line Development, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark

Richard Wyatt, PhD, Professor, Immunology and Microbiology, Scripps Research Institute

Alexei Yeliseev, PhD, Staff Scientist, Group Leader, LMBB, National Institute on Alcohol Abuse and Alcoholism, National Institute of Health

 

Optimizing Expression Platforms

[KEYNOTE] John K. Kawooya, PhD, Director, Biologics Optimization, Discovery Research, Amgen, Inc.

Richard Altman, MS, Field Application Scientist, Protein Expression, Biosciences Division, Life Sciences Solutions Group, Thermo Fisher Scientific

Sarah Barker, PhD, Director, Product Development, C-Lab Management Team, Centre for the Commercialization of Antibodies and Biologics (CCAB)

Yves Durocher, PhD, Research Officer, Bioprocess Engineering, National Research Council Canada

Sam Ellis, Vice President, Thomson Instrument Company

Dominic Esposito, PhD, Director, Protein Expression Laboratory, Frederick National Laboratory for Cancer Research

Peter Harms, PhD, Principal Engineer, Cell Culture, Genentech

Ying Huang, MD, PhD, Lab Head, Vaccine Design and Characterization, Preclinical R&D, GSK Vaccines

Dennis Karthaus, Director, Protein Products & Assays, IBA Lifesciences

Edward Kraft, PhD, Senior Scientific Manager, Biomolecular Resources, Genentech

Meiyappan Lakshmanan, PhD, Research Scientist & Group Leader, Systems Biology, Bioprocessing Technology Institute, A*STAR

Balaji Somasundaram, PhD, Strategy and Operations Manager, UQ Protein Expression Facility, The University of Queensland

Bjørn Voldborg, MSc, Director, CHO Cell Line Development, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark

Jessica Williamson, PhD, Protein Production Lead, UCB Biosciences

Ian Wilkinson, CSO, Absolute Antibody

Xiaotian Zhong, PhD, Senior Principal Scientist, Lab Head, BioMedicine Design, Pfizer Worldwide R&D

Yizhou Zhou, PhD, Scientist II, Cell Line Development, Biogen

 

Training Seminar Instructors:

David Bramhill, PhD, Founder, Bramhill Biological Consulting, LLC

Andrew R.M. Bradbury, MB BS, PhD, CSO, Specifica, Inc.

Matthew Brown, PhD, Applications Manager, Bioscience, Malvern Panalytical, Inc.

Trevor Deeks, PhD, QA/QC and GMP Consultant, Deeks Pharmaceutical Consulting Services, LLC

Thomas Laue, PhD, Professor Emeritus, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire

James D. Marks, MD, PhD, Chief of Performance Excellence, Zuckerberg San Francisco General Hospital and Trauma Center; Professor of Anesthesia, UCSF Department of Anesthesia and Perioperative Care

Kevin Mattison, PhD, Principal Scientist, Malvern Pananalytical, Inc.

Kevin Zen, PhD, Executive Director, Analytical Characterization, Formulation Development and Biologics Manufacturing, AnaptysBio Inc.

 

Short Course Instructors:

Wasfi AlAzzam, PhD, CSO, TechnoPharmaSphere (TPS)

Richard Altman, Field Application Scientist, Protein Expression, Biosciences Division, Life Sciences Solutions Group, Thermo Fisher Scientific

Henry C. Chiou, PhD, Director, Cell Biology, Life Science Solutions, Thermo Fisher Scientific

Rakesh Dixit, PhD, DABT, President & CEO, Bionavigen, LLC

Dominic Esposito, PhD, Director, Protein Expression Laboratory, Frederick National Laboratory for Cancer Research

Deb Harris, Managing Director, Industry Special Services, BDO USA LLP

Thomas Laue, PhD, Professor Emeritus, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire

Kevin Mattison, PhD, Principal Scientist, Malvern Pananalytical, Inc.

George Octavian Badescu, PhD, Vice President, Scientific Affairs, Heidelberg Pharma AG

Traian Sulea, PhD, Principal Research Officer, Human Health Therapeutics, Biotechnology Research Institute, National Research Council Canada

 

Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean


Update History
2019/11/14
Agenda updated
2019/11/06
Sponsor updated
2019/10/15
Speaker,Sponsor updated
2019/09/25
Agenda,Sponsor updated
2019/08/23
Sponsor updated




2020 Conferences & Training Seminars